Endogenous and combination retinoids are active in myelomonocytic leukemias

Authors

Orsola Di Martino, Washington University School of Medicine in St. Louis
Haixia Niu, Cincinnati Children's Hospital Medical Center
Gayla Hadwiger, Washington University School of Medicine in St. Louis
Heikki Kuusanmaki, University of Helsinki
Margaret A. Ferris, Washington University School of Medicine in St. Louis
Anh Vu, Washington University School of Medicine in St. Louis
Jeremy Beales, Washington University School of Medicine in St. Louis
Carl Wagner, Arizona State University
María P. Menéndez-Gutiérrez, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid
Mercedes Ricote, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid
Caroline Heckman, University of Helsinki
John S. Welch, Washington University School of Medicine in St. Louis

Journal

Haematologica

Publication Date

4-1-2021

Volume

106

Issue

4

First Page

1008

Last Page

1021

Document Type

Open Access Publication

DOI

10.3324/haematol.2020.264432

Rights and Permissions

Di Martino O, Niu H, Hadwiger G, et al. Endogenous and combination retinoids are active in myelomonocytic leukemias. Haematologica. 2021;106(4):1008-1021. Published 2021 Apr 1. doi:10.3324/haematol.2020.264432

Recommended Citation

Di Martino, Orsola; Niu, Haixia; Hadwiger, Gayla; Kuusanmaki, Heikki; Ferris, Margaret A.; Vu, Anh; Beales, Jeremy; Wagner, Carl; Menéndez-Gutiérrez, María P.; Ricote, Mercedes; Heckman, Caroline; and Welch, John S., "Endogenous and combination retinoids are active in myelomonocytic leukemias." Haematologica. 106, 4. 1008 - 1021. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10530